Help | RSS Feed



CASI Pharmaceuticals, Inc. (NASD:CASI) Seasonal Chart

Seasonal Chart Analysis

Analysis of the CASI Pharmaceuticals, Inc. (NASD:CASI) seasonal charts above shows that a Buy Date of January 1 and a Sell Date of April 15 has resulted in a geometric average return of 15.03% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 40.24% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

CASI Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the acquisition, development, and commercialization of therapeutics addressing cancer and other unmet medical needs with a commercial focus on the China market. The company’s technologies include an anti-angiogenesis program that focuses on the development of proprietary products that are intended to inhibit the abnormal growth of new blood vessels associated with cancer and certain causes of blindness. Another EntreMed technology is a blood-cell-permeation device that is designed to enhance the ability of red blood cells to deliver oxygen to organs and tissues.

To download CASI seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore